Study for the curative effect of Jianmin Immunepaste on patients with allergic rhinitis

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000033849

Enrollment

Unknown

Registered

2020-06-14

Start date

2020-06-20

Completion date

Unknown

Last updated

2020-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Allergic rhinitis

Interventions

Experimental group:using Jianmin Immunepaste for 3 months

Control group:General toothpast

Eligibility

Sex/Gender

All

Age

15 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Patients aged 15-65 years male and female; 2. The patients who are consistent with the clinical diagnosis basis of allergic rhinitis and have a course of more than 1 year. 3. Subjects who voluntarily participated in the study and were willing to sign informed consent.

Exclusion criteria

Exclusion criteria: 1. Pregnant and lactating women; 2. Patients undergoing allergen specific immunotherapy; 3. Patients with severe organ damage such as heart, liver and kidney; 4. patients who are participating in other clinical studies; 5. Patients who are not considered suitable for clinical study for other reasons.

Design outcomes

Primary

Measure	Time frame
Symptom score;	—

Countries

China

Contacts

Public ContactAilin Tao

The Second Affiliated Hospital of Guangzhou Medical university

AerobiologiaTao@163.com+86 20-34153520

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026